The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study
Open accessAbstract
OBJECTIVE: We aimed to perform an observational study of age at loss of independent ambulation (LoA) and side-effect profiles associated with different glucocorticoid corticosteroid (GC) regimens in Duchenne muscular dystrophy (DMD). METHODS: We studied 340 participants in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study (CINRG-DNHS). LoA was defined as continuous wheelchair use. Effects of prednisone or prednisolone (PRED)/deflazacort (DFZ), administration frequency, and dose were analyzed by time-varying Cox regression. Side-effect frequencies were compared using χ(2) test. RESULTS: Participants treated ≥1 year while ambulatory (n = 252/340) showed a 3-year median delay in LoA (p < 0.001). Fourteen different regimens were observed. Nondaily treatment was common for PRED (37%) and rare for DFZ (3%). DFZ was associated with later LoA than PRED (hazard ratio 0.294 ± 0.053 vs 0.490 ± 0.08, p = 0.003; 2-year difference in median LoA with daily administration, p < 0.001). Average dose was lower for daily PRED (0.56 mg/kg/d, 75% of recommended) than daily DFZ (0.75 mg/kg/d, 83% of recommended, p < 0.001). DFZ showed higher frequencies of growth delay (p < 0.001), cushingoid appearance (p = 0.002), and cataracts (p < 0.001), but not weight gain. CONCLUSIONS: Use of DFZ was associated with later LoA and increased frequency of side effects. Differences in standards of care and dosing complicate interpretation of this finding, but stratification by PRED/DFZ might be considered in clinical trials. This study emphasizes the necessity of a randomized, blinded trial of GC regimens in DMD. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that GCs are effective in delaying LoA in patients with DMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Self-citation
Cited by
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30024-3 · Cited by 1,370
Self-citationCorticosteroids for the treatment of Duchenne muscular dystrophy
Matthews, E., Brassington, R., Kuntzer, T., Jichi, F., & Manzur, A. Y. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003725.pub4 · Cited by 493
McDonald, C. M., Henricson, E. K., Abresch, R. T., Duong, T., Joyce, N. C., Hu, F., Clemens, P. R., Hoffman, E. P., Cnaan, A., Gordish-Dressman, H., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32160-8 · Cited by 479
Self-citationClemens, P. R., Rao, V. K., Connolly, A. M., Harper, A. D., Mah, J. K., Smith, E. C., McDonald, C. M., Zaidman, C. M., Morgenroth, L. P., Osaki, H., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1264 · Cited by 276
Self-citation
Metadata
- Authors
- Bello, L., Gordish-Dressman, H., Morgenroth, L. P., Henricson, E. K., Duong, T., Hoffman, E. P., Cnaan, A., McDonald, C. M., Abresch, R. T., Cregan, M., Goude, E., Johnson, L., Han, J., Joyce, N., Nicorici, A., Reddy, D., Viswanathan, V., Chidambaranathan, C., Kumar, S., Lakshmi, V., Reddappa, P., McAdam, L., Biggar, D., Eliasoph, L., Hosaki, E., Harris, V., Lee, G., Mah, J., Chiu, A., Haig, T., Harris, M., Rincon, N., Sanchez, K., Walker, L., Tulinius, M., Alhander, A., Ekstrom, A., Gustafsson, A., Kroksmark, A., Sterky, U., Wahlgren, L., Thangarajh, M., Leshner, R., Tesi-Rocha, C., Birkmeier, M., Kaminski, S., Kornberg, A., Ryan, M., Carroll, K., DeValle, K., Kennedy, R., Rodriguez, V., Villano, D., Nevo, Y., Adani, R., Chen-Joseph, L., Daana, M., Leve, A. B., Panteleyev-Yitshak, V., Simchovitz, E., Yaffe, D., Dubrovsky, A., Andreone, L., Bonaudo, F., Corderi, J., Mesa, L., Marco, P., Levi, L., Clemens, P., Abdel-Hamid, H., Bendixen, R., Bise, C., Craig, A., Karnavas, K., Matthews, C., Niizawa, G., Smith, A., Weimer, J., Connolly, A., Pestronk, A., Florence, J., Christenson, T., Golumbak, P., Malkus, B., Renna, R., Schierbecker, J., Seiner, C., Wulf, C., Teasley, J., Blair, S., Grillo, B., Monasterio, E., Bertorini, T., Igarashi, M., Barrett-Adair, M., Carter, K., Clift, J., Gatlin, B., Holloway, J., Young, R., Webster, R., North, K., Cornett, K., Gabriel, N., Miller, C., Rose, K., Wicks, S., Kolski, H., Chen, L., Kennedy, C., Gorni, K., Beneggi, M., Capone, L., Molteni, A., Morettini, V., Lotze, T., Gupta, A., Knight, A., Lott, B., McNeil, R., Orozco, G., Schlosser, R., Karachunski, P., Day, J., Chambers, G., Dalton, J., Erickson, A., Margolis, M., Marsh, J., Naughton, C., Bodensteiner, J., Kuntz, N., Coleman-Wood, K., Hoffman, A., Korn-Petersen, W., Carlo, J., Deliz, B., Espada, S., Fuste, P., Luciano, C., Torres, J., Ahmed, M., Arrieta, A., Bartley, N., Feng, J., Hu, F., Hunegs, L., Sund, Z., Tang, W., & Zimmerman, A.
- Venue
- Neurology
- Published
- 2015-09-22
- Volume
- 85
- Issue
- 12
- Pages
- 1048-1055
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2159586986
- Cited by
- 228
- References
- 1
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study. https://app.cochat.ai/papers/10.1212/wnl.0000000000001950
- The paper
- Bello, L., Gordish-Dressman, H., Morgenroth, L. P., Henricson, E. K., Duong, T., Hoffman, E. P., Cnaan, A., McDonald, C. M., Abresch, R. T., Cregan, M., Goude, E., Johnson, L., Han, J., Joyce, N., Nicorici, A., Reddy, D., Viswanathan, V., Chidambaranathan, C., Kumar, S., . . . Zimmerman, A. (2015). Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study. Neurology. https://doi.org/10.1212/wnl.0000000000001950
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.